India's Suven Life Sciences hits record high on positive drug trial results

Suven Life Sciences

18/09/2024 08:05

** Shares of biopharmaceutical co Suven Life Sciences
 SUVP.NS  rise as much as 7.8% to hit record high at 169.30
rupees
    ** SUVP says it got positive results from Phase-2a study of
Ropanicant
    ** Ropanicant is for treatment of moderate to severe major
depressive disorder
    ** Stock up 95.8% YTD




 (Reporting by Ashish Chandra in Bengaluru)
 ((ashish.chandra@thomsonreuters.com (+91 7982114624))